Marielena Vogel Saivish

Dr. Marielena Vogel Saivish

Faculdade de Medicina de São José do Rio Preto, São José do Rio Prêto, São Paulo, Brazil
+2
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2017 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
VCVivaldo Gomes da Costa
Vivaldo Gomes da Costa
VFValéria Christina de Rezende Féres
Valéria Christina de Rezende Féres
Marielena Vogel SaivishMarielena Vogel Saivish
Marielena Vogel Saivish
JGJoão Bosco de Lima Gimaque
João Bosco de Lima Gimaque
Marcos Lazaro MoreliMarcos Lazaro Moreli
Marcos Lazaro Moreli

16 November 2021 in Viruses
Verified
Journal Article
Open access
PDF file
Marielena Vogel SaivishMarielena Vogel Saivish
Marielena Vogel Saivish
VCVivaldo Gomes da Costa
Vivaldo Gomes da Costa
Gabriela de Lima MenezesGabriela de Lima Menezes
Gabriela de Lima Menezes
RSRoosevelt Alves Da Silva
Roosevelt Alves Da Silva
GSGislaine Celestino Dutra da Silva
Gislaine Celestino Dutra da Silva
MNMauricio Nogueira
Mauricio Nogueira
Rocio virus (ROCV) is a mosquito-borne flavivirus and human pathogen. The virus is indigenous to Brazil and was first detected in 1975 in the Sao Paulo State, and over a period of two years was responsible for several epidemics of meningoencephalitis in coastal communities leading to over 100 deaths. The vast majority of ROCV infections are believed to be subclinical and clinical manifestations can range from uncomplicated fever to fatal meningoencephalitis. Birds are the natural reservoir and amplification hosts and ROCV is maintained in nature in a mosquito-bird-mosquito transmission cycle, primarily involving Psorophora ferox mosquitoes. While ROCV has remained mostly undetected since 1976, in 2011 it re-emerged in Goiás State causing a limited outbreak. Control of ROCV outbreaks depends on sustainable vector control measures and public education. To date there is no specific treatment or licensed vaccine available. Here we provide an overview of the ecology, transmission cycles, epidemiology, pathogenesis, and treatment options, aiming to improve our ability to understand, predict, and ideally avert further ROCV emergence.

10 February 2023 in Viruses
Verified
Journal Article
Open access
PDF file
Marielena Vogel SaivishMarielena Vogel Saivish
Marielena Vogel Saivish
CPCarolina Pacca
Carolina Pacca
VCVivaldo Gomes da Costa
Vivaldo Gomes da Costa
Gabriela de Lima MenezesGabriela de Lima Menezes
Gabriela de Lima Menezes
RSRoosevelt Alves Da Silva
Roosevelt Alves Da Silva
MNMauricio Nogueira
Mauricio Nogueira
Ilhéus virus (ILHV) is a neglected mosquito-borne flavivirus. ILHV infection may lead to Ilhéus fever, an emerging febrile disease like dengue fever with the potential to evolve into a severe neurological disease characterized by meningoencephalitis; no specific treatments are available for this disease. This study assessed the antiviral properties of caffeic acid, an abundant component of plant-based food products that is also compatible with the socioeconomic limitations associated with this neglected infectious disease. The in vitro activity of caffeic acid on ILHV replication was investigated in Vero and A549 cell lines using plaque assays, quantitative RT-PCR, and immunofluorescence assays. We observed that 500 µM caffeic acid was virucidal against ILHV. Molecular docking indicated that caffeic acid might interact with an allosteric binding site on the envelope protein.

29 May 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
VCVivaldo Gomes da Costa
Vivaldo Gomes da Costa
Marielena Vogel SaivishMarielena Vogel Saivish
Marielena Vogel Saivish
RRRoger Luiz Rodrigues
Roger Luiz Rodrigues
RSRebeca Francielle de Lima Silva
Rebeca Francielle de Lima Silva
Marcos Lazaro MoreliMarcos Lazaro Moreli
Marcos Lazaro Moreli
RKRicardo Henrique Krüger
Ricardo Henrique Krüger
Canine morbillivirus (canine distemper virus, CDV) persists as a serious threat to the health of domestic dogs and wildlife. Although studies have been conducted on the frequency and risk factors associated with CDV infection, there are no comprehensive data on the current epidemiological magnitude in the domestic dog population at regional and national levels. Therefore, we conducted a cross-sectional study and included our results in a meta-analysis to summarize and combine available data on the frequency and potential risk factors associated with CDV infection. For the cross-sectional study, biological samples from dogs suspected to have canine distemper (CD) were collected and screened for viral RNA. Briefly, the PRISMA protocol was used for the meta-analysis, and data analyses were performed using STATA IC 13.1 software. CDV RNA was detected in 34% (48/141) of dogs suspected to have CD. Following our meta-analysis, 53 studies were selected for a total of 11,527 dogs. Overall, the pooled frequency of CDV positivity based on molecular and serological results were 33% (95% CI: 23–43) and 46% (95% CI: 36–57), respectively. The pooled subgroup analyses of clinical signs, types of biological samples, diagnostic methods and dog lifestyle had a wide range of CDV positivity (range 8–75%). Free-ranging dogs (OR: 1.44, 95% CI: 1.05–1.97), dogs >24 months old (OR: 1.83, 95% CI: 1.1–3) and unvaccinated dogs (OR: 2.92, 95% CI: 1.26–6.77) were found to be positively associated with CDV infection. In contrast, dogs <12 months old (OR: 0.36, 95% CI: 0.20–0.64) and dogs with a complete anti-CDV vaccination (OR: 0.18, 95% CI: 0.05–0.59) had a negative association. Considering the high frequency of CDV positivity associated with almost all the variables analyzed in dogs, it is necessary to immediately and continuously plan mitigation strategies to reduce the CDV prevalence, especially in determined endemic localities.

Verified
Journal Article
Open access
PDF file
Marielena Vogel SaivishMarielena Vogel Saivish
Marielena Vogel Saivish
Gabriela de Lima MenezesGabriela de Lima Menezes
Gabriela de Lima Menezes
RSRoosevelt Alves Da Silva
Roosevelt Alves Da Silva
MFMarina Fontoura
Marina Fontoura
JSJacqueline Farinha Shimizu
Jacqueline Farinha Shimizu
MNMauricio Nogueira
Mauricio Nogueira
Zika virus (ZIKV) has re-emerged in recent decades, leading to outbreaks of Zika fever in Africa, Asia, and Central and South America. Despite its drastic re-emergence and clinical impact, no vaccines or antiviral compounds are available to prevent or control ZIKV infection. This study evaluated the potential antiviral activity of quercetin hydrate against ZIKV infection and demonstrated that this substance inhibits virus particle production in A549 and Vero cells under different treatment conditions. In vitro antiviral activity was long-lasting (still observed 72 h post-infection), suggesting that quercetin hydrate affects multiple rounds of ZIKV replication. Molecular docking indicates that quercetin hydrate can efficiently interact with the specific allosteric binding site cavity of the NS2B-NS3 proteases and NS1-dimer. These results identify quercetin as a potential compound to combat ZIKV infection in vitro.

23 December 2023 in Current Research in Microbial Sciences
Verified
Journal Article
Open access
Marielena Vogel SaivishMarielena Vogel Saivish
Marielena Vogel Saivish
GMGabriela de Lima Menezes
Gabriela de Lima Menezes
RSRoosevelt Alves da Silva
Roosevelt Alves da Silva
LALeticia Ribeiro de Assis
Leticia Ribeiro de Assis
ITIgor da Silva Teixeira
Igor da Silva Teixeira
CPCarolina Pacca
Carolina Pacca
Oropouche virus (OROV) is an emerging vector-borne arbovirus found in South America that causes Oropouche fever, a febrile infection similar to dengue fever. It has a high epidemic potential, causing illness in over 500,000 cases diagnosed since the virus was first discovered in 1955. Currently, the prevention of human viral infection depends on vaccination, but availability for many viruses is limited, and they are classified as neglected viruses. At present, there are no vaccines or antiviral treatments available. An alternative approach to limiting the spread of the virus is to selectively disrupt viral replication mechanisms. Here, we demonstrate the inhibitory effect of acridones, which efficiently inhibited viral replication by 99.9 % in vitro. To evaluate possible mechanisms of action, we conducted tests with dsRNA, an intermediate in virus replication, as well as MD simulations, docking, and binding free energy analysis. The results showed a strong interaction between FAC21 and the OROV endonuclease, which possibly limits the interaction of viral RNA with other proteins. Therefore, our results suggest a dual mechanism of antiviral action, possibly caused by ds-RNA intercalation. In summary, our findings demonstrate that a new generation of antiviral drugs could be developed based on the selective optimization of molecules.